Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAFT900 in Children With Tinea Capitis
NCT02658292Phase 2Withdrawn
- Sponsor
- Merz
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of naftifine in tinea capitis, sponsored by Merz. Status: withdrawn.
02
Drugs
naftifine
03
Conditions
tinea capitis
Beyond the preview
Go deeper on NCT02658292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02658292.